James Samuel Shannon Xilio Therapeutics, Inc. (XLO) insider trading activity

James Samuel Shannon is of Xilio Therapeutics, Inc.. Currently has a direct ownership of 70,000 shares of XLO, which is worth approximately $47,600. The most recent transaction as insider was on Jun 17, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $17,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70K

n/a 3M change

n/a 12M change

Total Value Held $47,600

James Samuel Shannon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 17 2025	BUY Open market or private purchase	$17,250 $0.69 p/Share	25,000 Added 26.32%	70,000 Common Stock
Jun 16 2025	BUY Open market or private purchase	$31,049 $0.69 p/Share	45,000 Added 50.0%	45,000 Common Stock

Also insider at

HZNP

Horizon Therapeutics Public Ltd Co Healthcare

Director

MNKD

MANNKIND CORP Healthcare

JSS